Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Net Cash Flow (2023 - 2025)

Historic Net Cash Flow for Fractyl Health (GUTS) over the last 3 years, with Q3 2025 value amounting to $55.4 million.

  • Fractyl Health's Net Cash Flow rose 40605.86% to $55.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.0 million, marking a year-over-year decrease of 11758.39%. This contributed to the annual value of $33.9 million for FY2024, which is 31556.05% up from last year.
  • As of Q3 2025, Fractyl Health's Net Cash Flow stood at $55.4 million, which was up 40605.86% from -$19.8 million recorded in Q2 2025.
  • Fractyl Health's 5-year Net Cash Flow high stood at $88.2 million for Q1 2024, and its period low was -$25.4 million during Q1 2025.
  • In the last 3 years, Fractyl Health's Net Cash Flow had a median value of -$11.7 million in 2023 and averaged $2.6 million.
  • Within the past 5 years, the most significant YoY rise in Fractyl Health's Net Cash Flow was 102177.18% (2024), while the steepest drop was 20767.22% (2024).
  • Over the past 3 years, Fractyl Health's Net Cash Flow (Quarter) stood at -$11.3 million in 2023, then plummeted by 52.33% to -$17.2 million in 2024, then surged by 421.9% to $55.4 million in 2025.
  • Its Net Cash Flow stands at $55.4 million for Q3 2025, versus -$19.8 million for Q2 2025 and -$25.4 million for Q1 2025.